NABRIVA THERAPEUTICS AG has a total of 139 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 1999. It filed its patents most often in EPO (European Patent Office), China and Taiwan. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and environmental technology are CORSAIR PHARMA INC, MERRELL TORAUDE & CO and BYK NEDERLAND BV.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 30 | |
#2 | China | 11 | |
#3 | Taiwan | 10 | |
#4 | WIPO (World Intellectual Property Organization) | 10 | |
#5 | United States | 9 | |
#6 | Brazil | 8 | |
#7 | Hong Kong | 8 | |
#8 | Republic of Korea | 8 | |
#9 | Canada | 7 | |
#10 | Japan | 6 | |
#11 | Israel | 5 | |
#12 | EAPO (Eurasian Patent Organization) | 4 | |
#13 | Mexico | 4 | |
#14 | Malaysia | 3 | |
#15 | New Zealand | 3 | |
#16 | South Africa | 3 | |
#17 | Morocco | 2 | |
#18 | Tunisia | 2 | |
#19 | Ukraine | 2 | |
#20 | Australia | 1 | |
#21 | Croatia | 1 | |
#22 | Norway | 1 | |
#23 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Environmental technology | |
#4 | Biotechnology |
# | Name | Total Patents |
---|---|---|
#1 | Heilmayer Werner | 78 |
#2 | Riedl Rosemarie | 34 |
#3 | Mang Rosemarie | 33 |
#4 | Novak Rodger | 25 |
#5 | Thirring Klaus | 25 |
#6 | Spence Lee | 24 |
#7 | Bulusu Atchyuta Rama Chandra Murty | 24 |
#8 | Ferencic Mathias | 21 |
#9 | Ascher Gerd | 20 |
#10 | Strickmann Dirk | 19 |
Publication | Filing date | Title |
---|---|---|
EP2433926A1 | Pleuromutilin derivatives for use in the treatment of diseases mediated by microbes | |
MX2010009451A | Pleuromutilin derivatives for the treatment of diseases mediated by microbes. | |
WO2011032192A1 | Substituted clavulanic acid | |
EP2399904A1 | Process for the preparation of pleuromutilins | |
EP2390245A1 | Enantiomerically pure amines | |
EP2159220A1 | Organic compounds | |
EP2014645A1 | Pleuromutilin derivatives and their use as antimicrobials | |
EP2014640A1 | Pleuromutilin derivatives | |
EP1972618A1 | Pleuromutilin derivatives for the treatment of diseases mediated by microbes |